Literature DB >> 11175368

Proteins of the ETS family with transcriptional repressor activity.

G Mavrothalassitis1, J Ghysdael.   

Abstract

ETS proteins form one of the largest families of signal-dependent transcriptional regulators, mediating cellular proliferation, differentiation and tumorigenesis. Most of the known ETS proteins have been shown to activate transcription. However, four ETS proteins (YAN, ERF, NET and TEL) can act as transcriptional repressors. In three cases (ERF, NET and TEL) distinct repression domains have been identified and there are indications that NET and TEL may mediate transcription via Histone Deacetylase recruitment. All four proteins appear to be regulated by MAPKs, though for YAN and ERF this regulation seems to be restricted to ERKs. YAN, ERF and TEL have been implicated in cellular proliferation although there are indications suggesting a possible involvement of YAN and TEL in differentiation as well. Other ETS-domain proteins have been shown to repress transcription in a context specific manner, and there are suggestions that the ETS DNA-binding domain may act as a transcriptional repressor. Transcriptional repression by ETS domain proteins adds an other level in the orchestrated regulation by this diverse family of transcription factors that often recognize similar if not identical binding sites on DNA and are believed to regulate critical genes in a variety of biological processes. Definitive assessment of the importance of this novel regulatory level will require the identification of ETS proteins target genes and the further analysis of transcriptional control and biological function of these proteins in defined pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11175368     DOI: 10.1038/sj.onc.1204045

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  44 in total

1.  Sp100 interacts with ETS-1 and stimulates its transcriptional activity.

Authors:  Christine Wasylyk; Sophie E Schlumberger; Paola Criqui-Filipe; Bohdan Wasylyk
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  ERF nuclear shuttling, a continuous monitor of Erk activity that links it to cell cycle progression.

Authors:  Lionel Le Gallic; Laura Virgilio; Philip Cohen; Benoit Biteau; George Mavrothalassitis
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

3.  Mutant p53 cooperates with ETS2 to promote etoposide resistance.

Authors:  Phi M Do; Lakshman Varanasi; Songqing Fan; Chunyang Li; Iwona Kubacka; Virginia Newman; Krishna Chauhan; Silvano Rakeem Daniels; Maurizio Boccetta; Michael R Garrett; Runzhao Li; Luis A Martinez
Journal:  Genes Dev       Date:  2012-04-15       Impact factor: 11.361

4.  A novel zinc-finger protein ZNF436 suppresses transcriptional activities of AP-1 and SRE.

Authors:  Yongqing Li; Xiaoyan Du; Fang Li; Yun Deng; Zhiyuan Yang; Yuequn Wang; Zhonglu Pen; Zequn Wang; Wuzhou Yuan; Chuanbing Zhu; Xiushan Wu
Journal:  Mol Biol Rep       Date:  2006-11-07       Impact factor: 2.316

5.  ZNF418, a novel human KRAB/C2H2 zinc finger protein, suppresses MAPK signaling pathway.

Authors:  Yongqing Li; Dan Yang; Yan Bai; Xiaoyang Mo; Wen Huang; Wuzhou Yuan; Zhaochu Yin; Yun Deng; Oleg Murashko; Yuequn Wang; Xiongwei Fan; Chuanbing Zhu; Karen Ocorr; Rolf Bodmer; Xiushan Wu
Journal:  Mol Cell Biochem       Date:  2007-12-15       Impact factor: 3.396

6.  Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways.

Authors:  Serena Ghisletti; Wendy Huang; Kristen Jepsen; Chris Benner; Gary Hardiman; Michael G Rosenfeld; Christopher K Glass
Journal:  Genes Dev       Date:  2009-03-15       Impact factor: 11.361

Review 7.  Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-09-25       Impact factor: 8.250

Review 8.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

9.  The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.

Authors:  Monica Cardone; Ayten Kandilci; Cintia Carella; Jonas A Nilsson; Jennifer A Brennan; Sema Sirma; Ugur Ozbek; Kelli Boyd; John L Cleveland; Gerard C Grosveld
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo.

Authors:  Gong-Hong Wei; Gwenael Badis; Michael F Berger; Teemu Kivioja; Kimmo Palin; Martin Enge; Martin Bonke; Arttu Jolma; Markku Varjosalo; Andrew R Gehrke; Jian Yan; Shaheynoor Talukder; Mikko Turunen; Mikko Taipale; Hendrik G Stunnenberg; Esko Ukkonen; Timothy R Hughes; Martha L Bulyk; Jussi Taipale
Journal:  EMBO J       Date:  2010-06-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.